ITGAM and neoplasm: CD11b is a marker expressed on innate cell subtypes, such as macrophages, granulocytes, and natural killer (NK) cells, and previous studies have identified the activation of CD11b as a promising strategy to enhance adaptive anti-tumor immunity in lung cancer [46].